Abstract
Safety and efficacy of glycoprotein IIb/IIIa inhibitors in patients treated with percutaneous coronary intervention early after receiving thrombolytic therapy
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have